Literature DB >> 10689365

Galanin receptor subtypes.

T A Branchek1, K E Smith, C Gerald, M W Walker.   

Abstract

The neuropeptide galanin, which is widely expressed in brain and peripheral tissues, exerts a broad range of physiological effects. Pharmacological studies using peptide analogues have led to speculation about multiple galanin receptor subtypes. Since 1994, a total of three G-protein-coupled receptor (GPCR) subtypes for galanin have been cloned (GAL1, gal2 and gal3). Potent, selective antagonists are yet to be found for any of the cloned receptors. Major challenges in this field include linking the receptor clones with each of the known physiological actions of galanin and evaluating the evidence for additional galanin receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10689365     DOI: 10.1016/s0165-6147(00)01446-2

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  98 in total

1.  Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease.

Authors:  R A Steiner; J G Hohmann; A Holmes; C C Wrenn; G Cadd; A Juréus; D K Clifton; M Luo; M Gutshall; S Y Ma; E J Mufson; J N Crawley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

2.  Enhanced hippocampal noradrenaline and serotonin release in galanin-overexpressing mice after repeated forced swimming test.

Authors:  Takashi Yoshitake; Fu-Hua Wang; Eugenia Kuteeva; Kristina Holmberg; Masatoshi Yamaguchi; Jacqueline N Crawley; Robert Steiner; Tamas Bartfai; Sven Ove Ogren; Tomas Hökfelt; Jan Kehr
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-30       Impact factor: 11.205

3.  Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests.

Authors:  Tamas Bartfai; Xiaoying Lu; Hedieh Badie-Mahdavi; Alasdair M Barr; Andrey Mazarati; Xiao-Ying Hua; Tony Yaksh; Gebhard Haberhauer; Susana Conde Ceide; Laurent Trembleau; Laszlo Somogyi; Lenz Kröck; Julius Rebek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

4.  Antinociceptive effects induced by intra-lateral habenula complex injection of the galanin receptor 1 agonist M617 in rats.

Authors:  Li-Bo Fu; Ying Wang; Xiao-Xiao Sun; Xiao-Xia Liu; Ying Wang; Wen Zhuang
Journal:  Exp Brain Res       Date:  2015-11-02       Impact factor: 1.972

5.  The activation of galanin receptor 2 plays an antinociceptive effect in nucleus accumbens of rats with neuropathic pain.

Authors:  Yan Dong; Chong-Yang Li; Xiao-Min Zhang; Ya-Nan Liu; Shuang Yang; Meng-Nan Li; Shi-Lian Xu
Journal:  J Physiol Sci       Date:  2021-02-05       Impact factor: 2.781

6.  Synthesis of galmic: a nonpeptide galanin receptor agonist.

Authors:  Susana Conde Ceide; Laurent Trembleau; Gebhard Haberhauer; Laszlo Somogyi; Xiaoying Lu; Tamas Bartfai; Julius Rebek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-19       Impact factor: 11.205

7.  Galanin type 1 receptor knockout mice show altered responses to high-fat diet and glucose challenge.

Authors:  E P Zorrilla; M Brennan; V Sabino; X Lu; T Bartfai
Journal:  Physiol Behav       Date:  2007-01-16

8.  Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.

Authors:  Joanna L Elson; Rafael Kochaj; Richard Reynolds; Ilse S Pienaar
Journal:  Neurotox Res       Date:  2017-12-07       Impact factor: 3.911

9.  Galanin-induced decreases in nucleus accumbens/striatum excitatory postsynaptic potentials and morphine conditioned place preference require both galanin receptor 1 and galanin receptor 2.

Authors:  Emily B Einstein; Yukiko Asaka; Mark F Yeckel; Michael J Higley; Marina R Picciotto
Journal:  Eur J Neurosci       Date:  2013-02-07       Impact factor: 3.386

10.  Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice.

Authors:  Jefferson W Kinney; Grzegorz Starosta; Andrew Holmes; Craige C Wrenn; Rebecca J Yang; Ashley P Harris; Katharine C Long; Jacqueline N Crawley
Journal:  Learn Mem       Date:  2002 Jul-Aug       Impact factor: 2.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.